Dynavax Technologies
DVAX
#4934
Rank
ยฃ1.34 B
Marketcap
ยฃ11.48
Share price
0.00%
Change (1 day)
8.25%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Market cap: ยฃ1.34 Billion

As of February 2026 Dynavax Technologies has a market cap of ยฃ1.34 Billion. This makes Dynavax Technologies the world's 4934th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ1.34 B0.56%
2025ยฃ1.34 B-1.52%
2024ยฃ1.36 B-3.99%
2023ยฃ1.41 B26.41%
2022ยฃ1.12 B-10.26%
2021ยฃ1.25 B247.56%
2020ยฃ0.35 B-1.67%
2019ยฃ0.36 B-19.26%
2018ยฃ0.45 B-45.95%
2017ยฃ0.83 B579.8%
2016ยฃ0.12 B-80.32%
2015ยฃ0.62 B120.02%
2014ยฃ0.28 B-8.77%
2013ยฃ0.31 B-3.12%
2012ยฃ0.32 B18.99%
2011ยฃ0.27 B13.02%
2010ยฃ0.23 B403.15%
2009ยฃ47.63 M108.52%
2008ยฃ22.84 M-77.67%
2007ยฃ0.10 B-45.05%
2006ยฃ0.18 B222.05%
2005ยฃ57.79 M-41.41%
2004ยฃ98.65 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
ยฃ113.99 B 8,353.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ151.54 B 11,137.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ21.34 B 1,483.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ137.72 B 10,113.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ229.14 B 16,892.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ235.39 B 17,356.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ88.10 B 6,433.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
ยฃ82.2 M-93.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ29.26 B 2,069.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel